Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication

References

• Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol 2004; 103:698–709.
   PubMed Web of Science ®Google Scholar
• Robertson E, Grace S, Wallington T, Stewart DE. Antenatal risk factors for postpartum depression: a synthesis of recent literature. Gen Hosp Psychiatry 2004; 26:289–295.
   PubMed Web of Science ®Google Scholar
• Halbreich U. The association between pregnancy processes, preterm delivery, low birth weight, and postpartum depressions: the need for interdisciplinary integration. Am J Obstet Gynecol 2005; 193:1312–1322.
   PubMed Web of Science ®Google Scholar
• Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich LA. Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry 2005; 162:79–91.
   PubMed Web of Science ®Google Scholar
• Murray L, Cooper P. Effects of postnatal depression on infant development. Arch Dis Child 1997; 77:99–101.
   PubMed Web of Science ®Google Scholar
• O’Connor TG, Ben-Shlomo Y, Heron J, Golding J, Adams D, Glover V. Prenatal anxiety predicts individual differences in cortisol in pre-adolescent children. Biol Psychiatry 2005; 58:211–217.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Practice guidelines for major depressive disorder in adults. Am J Psychiatry 1993; 150 (Suppl 4):1–26
   PubMedGoogle Scholar
• Cohen LS, Altshuler LL, Harlow BL . Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 2006; 295:499–507.
   PubMed Web of Science ®Google Scholar
• Andrade SE, Raebel MA, Brown J . Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008; 198:194e1–e5.
   Web of Science ®Google Scholar
• Hendrick V, Stowe ZN, Altshuler LL, Hwang S, Lee E, Haynes D. Placental passage of antidepressant medications. Am J Psychiatry 2003; 160:993–996.
   PubMed Web of Science ®Google Scholar
• Rampono J, Proud S, Hackett LP, Kristensen JH, Ilett KF. A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate. Int J Neuropsychopharmacol 2004; 7:329–334.
   PubMed Web of Science ®Google Scholar
• Chambers CD, Hernandez-Diaz S, van Marter LJ . Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006; 354:579–587.
   PubMed Web of Science ®Google Scholar
• Zeskind PS, Stephens LE. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehaviour. Pediatrics 2004; 113:368–376.
   PubMed Web of Science ®Google Scholar
• Nordeng H, Lindemann R, Perminov KV, Reikvam A. Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors. Acta Paediatr 2001; 90:288–291.
   PubMed Web of Science ®Google Scholar
• Casper RC, Fleisher BE, Lee-Ancajas JC . Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 2003; 142:402–408.
   PubMed Web of Science ®Google Scholar
• Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 2006; 63:898–906.
   PubMed Web of Science ®Google Scholar
• Wen SW, Yang Q, Garner P . Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol 2006; 194:961–966.
   PubMed Web of Science ®Google Scholar
• Kallen B. Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med 2004; 158: 312–316.
   PubMed Web of Science ®Google Scholar
• Cohen LS, Heller VL, Bailey JW, Grush L, Ablon JS, Bouffard SM. Birth outcomes following prenatal exposure to fluoxetine. Biol Psychiatry 2000; 48:996–1000.
   PubMed Web of Science ®Google Scholar
• Kulin NA, Pastuszak A, Sage SR . Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA 1998; 279:609–610.
   PubMed Web of Science ®Google Scholar
• Hendrick V, Smith LM, Suri R, Hwang SM, Haynes D, Altshuler L. Birth outcomes after prenatal exposure to antidepressant medication. Am J Obstet Gynecol 2003; 188:812–815.
   PubMed Web of Science ®Google Scholar
• Ericson A, Kallen B, Wiholm B-E. Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol 1999; 55:503–508.
   PubMed Web of Science ®Google Scholar
• Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988; 8:77–100.
   Web of Science ®Google Scholar
• Katz R, Katz J, Shaw BF. Beck Depression Inventory and Hopelessness Scale. The use of psychological testing for treatment planning and outcomes assessment. Maruish, Mark E. The use of psychological testing for treatment planning and outcomes assessment (2nd). Mahwah: Lawrence Erlbaum Associates Publishers; 1999: 921–933.
   Google Scholar
• Galbally M, Lewis AJ, Lum J, Buist AE. Serotonin discontinuation syndrome following in utero exposure to anti-depressant medication: a prospective controlled study. Aust N Z J Psychiatry 2009; 43:846–854.
   PubMed Web of Science ®Google Scholar
• Cohen J. Statistical power analysis for the behavioral sciences (2nd). Hillsdale, NJ: Erlbaum, 1998.
   Google Scholar